Background: Olfactory dysfunction significantly influences patients' quality of life. Chitosan has been reported to support neuron and Schwann cell growth and even leads to orient axonal growth. However, researchers have yet to explore whether chitosan solution can promote differentiation of olfactory receptor neurons of the olfactory neuroepithelium and be used for treating olfactory dysfunction.
O lfactory dysfunction significantly influences patients' life quality, inclusive of taste, appetite and even an ability to identify nearby environmental hazards. 1 In particular, this deficit may be linked with a depressed mood, suicidal ideation, and early stage neurodegenerative diseases. 2, 3 In the general population, hyposmia varies from 13 to 18%, and anosmia varies from 4 to 6%. 4 Olfactory malfunction is commonly attributed to the atrophy of olfactory neuroepithelium as age increases, to a viral infection of upper respiratory tract, and to a disorder of neuron connection owing to head trauma 2, 5 ; among these, the first two mainly result from the number and degree of differentiation of olfactory receptor neurons (ORN). The olfactory neuroepithelium, which comprises specialized olfactory glands, and ORNs surrounded by their olfactory ensheathing cells, has the unique ability of continual neurogenesis in peripheral neuron system of adult mammals. 6 Although promising findings have been achieved in many approaches, such as use of vitamin A, minerals, and steroids, these are still inadequate in clinical treatment. [7] [8] [9] Consequently, new treatment modalities for patients with olfactory loss need to be developed.
Chitosan is a cationic polysaccharide with a variable number of randomly located D-glucosamine and N-acetyl-glucosamine groups. It fulfills several biologic roles, including enhancing synthesis and deposition of extracellular matrix, prolonging half-life of growth factors, and applying as wound healing dressings. 10 Moreover, chitosan supports neuron and Schwann cell growth, and even leads to orient axonal growth. 11, 12 However, researchers have yet to explore whether chitosan solution can promote ORN differentiation of olfactory neuroepithelial cells (ONC) and be used for treating olfactory dysfunction. This investigation evaluated the effect of chitosan solution on ONCs, which is an essential step in treating olfactory dysfunction and facilitating regeneration of the olfactory neuroepithelium.
METHODS

Isolation and Culture of ONCs
Olfactory neuroepithelium was isolated from embryonic day 17 of Wistar rats, and 40 embryos per trial were used. After isolation, olfactory neuroepithelia were digested in Hank's Balanced Salt Solution (Roche Molecular Biochemicals, Indianapolis, IN), which contained 0.125% trypsin/EDTA for 30 minutes at 37°C. The cell suspension was then filtered through a 70-m cell strainer to eliminate cell aggregates and debris, and adjusted to 24 ϫ 10 4 cells/mL (equivalent to 5 ϫ 10 4 cells/cm 2 ). Finally, a 2-mL cell suspension was added to six wells coated with 0.85 g/cm 2 poly-L-lysine and three wells for each condition. The results were observed in five independent experiments. ONCs were cultured at 37°C in humidified 5% CO 2 and 95% air atmosphere. This experimental protocol was approved by the institutional animal care and use committee of Far Eastern Memorial Hospital (agreement IACUC-2015-MOST-18). Cell morphology was observed under an inverse phase-contrast microscope (TS-10; Nikon, Tokyo, Japan) and a scanning electron microscope (S-4800; Hitachi, Tokyo, Japan).
Culture Medium
ONC medium comprised Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (Invitrogen, California), 20 ng/mL basic fibroblast growth factor, 20 ng/mL epidermal growth factor, 2% B-27 serumfree supplement and 1% penicillin-streptomycin. To prepare the chitosan-containing medium, chitosan (C-3646; Sigma-Aldrich, St. Louis, MO) was mixed with culture medium (0.1 mg/mL) and adjusted to pH 7.2 with NaOH. Particularly, a 1 wt. % solution of chitosan was prepared by dissolving chitosan in 0.5 M acetic acid. 13 Hence, a mock culture medium was prepared similarly to the chitosan-containing
ONC medium by mixing the same amount of acetic acid and NaOH without adding chitosan.
Immunocytochemistry
The cultured cells were fixed in 4% paraformaldehyde and permeabilized with 0.1% Triton X-100 (X100; Sigma-Aldrich, St. Louis, MO) for 5 minutes at room temperature. For immunohistochemistry, the olfactory neuroepithelium was fixed in 10% paraformaldehyde at 4°C overnight, decalcified, and embedded with paraffin. After pretreatment, the cells or paraffin sections were blocked in 3% bovine serum albumin for 20 minutes and incubated with primary antibodies diluted in 3% bovine serum albumin overnight. The primary antibodies and their dilution were used in this study: anticytokeratin 5 (CK5) (Ab52635, 1:100; Abcam, Cambridge, UK), anti-achaete-scute homolog 1 (Ascl1) (Ab74065, 1:1000; Abcam), anti-␤III tubulin (Ab118627, 1:1000; Abcam), anti-olfactory marker protein (OMP) (ab62144, 1:100; Abcam), anti-OMP (NB110-74751, 1:100; Novus, CO), anti-olfactory neuron specific-G protein (G olf ) (GTX110520, 1:100; GeneTex, CA), and anti-adenylate cyclase type 3 (ADCY3) (Ab125093; 1:1000; Abcam). Dylight 488-or Alexa Fluor 555-conjugated secondary antibodies (Abcam, Cambridge, UK) were adopted to visualize the signal by reacting with cells for 1.5 hours at room temperature. In addition, 4',6-diamidino-2-phenylindole (DAPI)-and rhodamine-conjugated phalloidin were used to counterstain nuclear and cytoskeletal markers, respectively. Particularly, the cells were incubated with 5-bromo-2Ј-deoxyuridine for 48 hours to let 5-bromo-2Ј-deoxiuridine incorporation during DNA synthesis in replicating cells. These immunostained cells were visualized by using indirect fluorescence under a confocal microscope (LSM510; Carl Zeiss, Oberkochen, Germany).
Western Blot Analysis
ONC lysates were obtained from individual culture wells by using a radioimmunoprecipitation assay lysis buffer that contained protease inhibitor cocktail tablets (Roche Diagnostics, IN). These samples were then denatured and separated by 12% sodium dodecyl sulfatepolyacrylamide gel electrophoresis, and blotted onto polyvinylidene fluoride membranes (Millipore, Billerica, MA). After blocking in a CIS-blocking buffer (CIS-Biotechnology, Taichung City, Taiwan) at room temperature for 60 seconds, the membranes were probed with various primary antibodies at 4°C overnight. Membranes were incubated with horseradish peroxidase-conjugated secondary antibodies for 1.5 hours, and, finally, visualized by using enhanced chemiluminescence (Millipore). After detachment of previous primary antibodies, the membranes were also probed with Glyceraldehyde-3-Phosphate Dehydrogenase antibodies, which served as an internal control. Images of Western blotting were acquired by UVP BioSpectrum 810 and analyzed by Vision Works LS software (UVP, CA).
Statistical Analysis
All the measurements were presented as mean Ϯ standard deviation. Statistical significance was computed with one-way analysis of variance, followed by a Fisher's Least Significant Difference test with p Ͻ 0.05. All statistical analyses were conducted by using SigmaPlot v12.5 (Systat Software, CA).
RESULTS
Immunocytochemical and Morphologic Characterization of ONCs
Primary rat ONCs were obtained from day 17 embryos of Wistar rats. With regard to the characterization of the cells, CK5 and Ascl1 were adopted to determine the purity of the cell population. CK5 is a progenitor marker of the olfactory neuroepithelium and Ascl1 acts as a key transcription factor to initiate a differentiation program in the olfactory lineage 14 CK5 immunoreactivity was present in the cytoplasm of horizontal basal cells, whereas Ascl1 was detected in the nucleus of globose basal cells ( Fig. 1 A) . In addition, some CK5positive cells also expressed 5-bromo-2Ј-deoxiuridine, a proliferation marker localized in the nucleus ( Fig. 1 A (b) ). Analysis of these data indicated that primary rat ONCs expressed early olfactory lineage markers, consistent with previous reports. 6 During the cultural period, ONCs successfully adhered to the substrate in both chitosan and control groups at day 3. In contrast to irregular and flattened cells observed in the control groups, ONCs treated with chitosan exhibited a bipolar morphology with asymmetric processes, which coincided with previous reports. 15 Further scanning electron microscope images confirmed that there were bipolar cells in chitosan groups (Fig. 1 B) .
Expressions of ORNs in ONCs
OMP is a representative marker of mature ORNs, whereas ␤III tubulin is widely accepted as indicating immature ORNs. 16, 17 First, to demonstrate antibody specificity, the native olfactory neuroepithelium of adult rats was labeled with ␤III tubulin and OMP. In native regions, the dendrites of mature ORNs were located in the apical surface of the olfactory neuroepithelium, whereas ␤III tubulin was detected throughout the lower layer of the neuroepithelium (Fig. 2 A) . This result was compatible with a previous study. 18 Furthermore, the immunofluorescence analyzed at day 9 revealed numerous ␤III tubulin-positive cells with slender and long processes located in the cytoplasm and cytoskeleton (Fig. 2 B) . In contrast, individual ORNs displayed intense OMP immunoreactivity located in cytoplasm in the chitosan groups (Fig. 2 B-D) . The Western blotting assay further con- firmed these expression patterns. From days 3 to 9, the expression level of ␤III tubulin gradually reduced, but the expression level of OMP rose in the chitosan groups (Fig. 2 C-E) . Particularly, the control groups had a significantly lower expression of OMP than the chitosan groups at day 9. The ratio of OMP relative to Glyceraldehyde-3-Phosphate Dehydrogenase in the control at day 9 was 0.3 Ϯ 0.17, in contrast to 0.8 Ϯ 0.18 (mean Ϯ SD) in the chitosan groups, which exhibited a significant difference ( Fig. 2 E) (p Ͻ 0.05). The finding indicated that chitosan promoted the maturation of ORNs during this period.
Expressions of Signal Transduction Apparatus of ORNs
G olf and ADCY3 are essential components of signal transduction pathway for odorant receptors and neurotransmitter response. Results of immunostaining analysis showed that OMP-positive cells cultured with chitosan also expressed G olf and ADCY3 (Fig. 3 A) . G olf and ADCY3 were found throughout their cell bodies and membranes, respectively. The localization of these signal transduction apparatuses was in accord with previous reports. 19 Western blot analysis of G olf and ADCY3 further confirmed the results (Fig. 3 B-D) and indicated that ORNs treated with chitosan expressed more signal transduction apparatuses than ORNs without treatment at day 9 (p Ͻ 0.05). Therefore, chitosan-treated ONCs not only differentiated into ORNs but also enhanced their signal transduction apparatuses.
DISCUSSION
Different forms of chitosan can be adopted as substrates in tissue engineering. Chitosan films preserve the inherent original phenotype of melanocytes and keratinocytes, which makes them well suited for wound dressings. 20 In addition, chitosan in its soluble form facilitates salivary gland branching and is also beneficial in drug delivery. 21, 22 Soluble chitosan is clinically more suitable than film chitosan for developing topical nasal sprays for olfactory dysfunction; therefore, this work considered the impact of soluble chitosan on the differentiation of ONCs and formation of signal transduction apparatuses in ORNs. New ORNs have to possess OMP and even signal transduction apparatuses to define the restorative olfaction. Experimental results of this study demonstrated that the expression level of OMP in the chitosan groups increased over days and had the highest value on day 9 (Fig. 2 E) . In addition, the expression level of signal transduction apparatuses also has the similar trend ( Fig. 3 C and D) . Hence, soluble chitosan can promote ONCs to differentiate into mature and functional ORNs. The mechanism may be the interaction between chitosan and ONCs. Because chitosan comprises a combination of D-glucosamine and N-acetyl-glucosamine, and the olfactory neuroepithelium is rich in numerous glycoconjugates to determine cell fate, 23 chitosan may interact with glycoconjugates to promote regeneration of the functional olfactory neuroepithelium.
The major region of a mammalian nose is covered by respiratory epithelium, whereas the area of olfactory neuroepithelium shows interspecies differences, which is never Ͼ10% of the nasal cavity in human. 24 Most olfactory impairment is due to atrophy of the olfactory neuroepithelium or metaplasia into the squamous respiratory epithelium. 25 These results demonstrated that chitosan can promote ONCs entering the terminal differentiation stage of ORNs. In addition, according to our previous study, nasal epithelial cells cannot grow well on chitosan films and chitosan inhibits re-epithelialization and mucociliary differentiation of nasal epithelial cells during the sinonasal wound healing process. 26, 27 Therefore, chitosan may promote the olfactory neuroepithelium development and simultaneously protect olfactory neuroepithelium from metaplasia.
Another benefit of using chitosan to treat olfactory dysfunction is its excellent mucoadhesive property. Mucus is present in different forms, which include a gel layer, solution, and suspension. Mucus adheres to the mucosal surface, which protects epithelial cells from infection and dehydration. 28 Chitosan can interact with mucin and adhere to nasal mucosa owing to its special molecular properties 29 and, therefore, may prolong the efficacy of treatment and be appropriate for topical administration in the nasal system. In addition, future drug development may use chitosan as a carrier to achieve a syngeneic effect. To our knowledge, this study was the first report to demonstrate that a chitosan solution can promote ORN differentiation of ONCs and, in the future, may provide a new therapeutic strategy for treating olfactory dysfunction that results from degeneration of the olfactory neuroepithelium.
CONCLUSION
The experimental results demonstrate that soluble chitosan promote differentiation of ONCs because of its role in ORN differentiation, neurite outgrowth, and signal transduction apparatuses expression.
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